BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12081637)

  • 1. The effects on GP prescribing of joining a commissioning group.
    Ashworth M; Armstrong D; Lloyd D; Colwill S
    J Clin Pharm Ther; 2002 Jun; 27(3):221-8. PubMed ID: 12081637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivating general practitioners to change their prescribing: the incentive of working together.
    Ashworth M; Armstrong D; Colwill S; Cohen A; Balazs J
    J Clin Pharm Ther; 2000 Apr; 25(2):119-24. PubMed ID: 10849189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing indicators and their use by primary care groups to influence prescribing.
    Ashworth M; Golding S; Majeed A
    J Clin Pharm Ther; 2002 Jun; 27(3):197-204. PubMed ID: 12081633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication prescribing advice and drug utilization: a review from the United Kingdom.
    Law J; Thompson A
    Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
    Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New medicines in primary care: a review of influences on general practitioner prescribing.
    Mason A
    J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do general practices which provide an acupuncture service have low referral rates and prescription costs? A pilot survey.
    Johnson G; White A; Livingstone R
    Acupunct Med; 2008 Dec; 26(4):205-13. PubMed ID: 19098691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.
    Brett J; Elshaug AG; Bhatia RS; Chalmers K; Badgery-Parker T; Pearson SA
    Implement Sci; 2017 May; 12(1):58. PubMed ID: 28468629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of financial and educational incentives on rational prescribing. A state-space approach.
    Pechlivanoglou P; Wieringa JE; de Jager T; Postma MJ
    Health Econ; 2015 Apr; 24(4):439-53. PubMed ID: 24519732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting and analysing practice prescribing data.
    Nicholls J
    Community Nurse; 2000 Jul; 6(6):39-42. PubMed ID: 12778649
    [No Abstract]   [Full Text] [Related]  

  • 19. Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database.
    Ashworth M; Latinovic R; Charlton J; Cox K; Rowlands G; Gulliford M
    J Public Health (Oxf); 2004 Sep; 26(3):268-74. PubMed ID: 15454595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.